XENE

Xenon Pharmaceuticals Inc
Data: 2026-07-02
$60.96
Price
1.09%
Change
$63.95
52W High
$30.00
52W Low

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Quick Stats
Jul 02, 2026

53.9

AI Score

HOLD

0.88

Volume Ratio

Aug 10, 2026

Next Earnings

15

+ve Days (30d)

15

-ve Days (30d)

XENE Stock Summary

Last updated Jul 02, 2026

XENE is currently trading at $60.96, positioned above its 200-day moving average of $47.38, indicating a long-term uptrend. The stock has a 52-week range of $30 to $63.95.

Technical Analysis: The 50-day moving average stands at $55.05, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 74.124, suggesting the stock is in overbought territory (bullish but caution advised).

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.171, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates XENE at 53.9/100 with a HOLD recommendation.

XENE (Xenon Pharmaceuticals Inc) Indicators

Last updated Jul 02, 2026

Indicator Value
RSI(14) 74.124
CMF (20) 0.171
ROC (10) 14.586
ADX (14) 27.716
Indicator Value
MACD (12,26,9) 1.646
AROONOSC (14) 100.0
WILLAMS %R (14) -6.64
MFI (14) 93.406
XENE Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

XENE Price vs Max Options Open Interest
XENE Max Change In Options Open Interest

XENE Options - Sort by Max open Interest (near term)

3rd July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

XENE Daily Out of Money Options - Sort by Max open Interest (near term)

3rd July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

XENE Daily In the Money Options - Sort by Max open Interest (near term)

3rd July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

XENE Most Active Options by Volume(near term)

3rd July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Xenon Pharmaceuticals Inc is above both 50 Day and 200 Day SMA which is considered Bullish.

XENE Moving Averages Analysis

Xenon Pharmaceuticals Inc has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jul 02, 2026

Xenon Pharmaceuticals Inc has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jul 02, 2026

XENE (Xenon Pharmaceuticals Inc) Simple Moving Averages

Moving Averages are last updated Jul 02, 2026

Days MA
10 57.62
20 54.9
30 54.59
50 55.05
100 53.35
200 47.38

XENE Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 5.8 billion
Earnings/Share ($) -4.7
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -4.8103
EPS Estimate Next Year ($) -5.0094
WallStreet Target Price ($) 80.5605
Most Recent Quarter